GPGrossPatternRESEARCH SYSTEM
SEC CHECK STALE
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ANG-PD · Dec 31, 2015

American National Group Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001039828-16-000136Insurance
Cash8thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.cash

$397.7M · CORE · VALID

Policy-benefit growth25thOwn-history percentile · N=8
Evidence method

Yoy · gp.insurance.policy_benefits

8.71% · OPTIONAL · VALID

Net-income growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.net_income

74.44% · CORE · NOT_ENOUGH_HISTORY

Premium growth38thOwn-history percentile · N=8
Evidence method

Yoy · gp.insurance.premiums

10.50% · CORE · VALID

Revenue growth38thOwn-history percentile · N=8
Evidence method

Yoy · gp.fundamentals.revenue

-29.97% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History51 statesSelf-history eligible
Period transition

What moved in the state?

Cash Decreased
Previous
$523.6M
Current
$397.7M
Delta
-$125.9M
Claims Growth Decreased
Previous
20.31%
Current
8.71%
Delta
-11.60%
Earnings Growth Increased
Previous
43.49%
Current
74.44%
Delta
30.95%
Premium Growth Decreased
Previous
37.93%
Current
10.50%
Delta
-27.43%
Revenue Growth Increased
Previous
-72.42%
Current
-29.97%
Delta
42.45%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.